Skip to content
10-Q

Quarterly Report

Lyra Therapeutics, Inc. LYRA

0001193125-25-277564

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 1.77M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.77M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.48M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 1.31M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 1.3M sh
Capex Q3 2025 · Sep 30, 2025 $20K
Capex Q3 2025 · Sep 30, 2024 $2.4M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$22.79M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$58.66M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $22.06M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $40.58M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$4.33M
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.62M
Stockholders Equity Q3 2025 · Mar 31, 2025 $3.87M
Stockholders Equity Q3 2025 · Dec 31, 2024 $11.59M
Stockholders Equity Q3 2025 · Sep 30, 2024 $20.62M
Stockholders Equity Q3 2025 · Jun 30, 2024 $30.98M
Stockholders Equity Q3 2025 · Mar 31, 2024 $77.5M
Stockholders Equity Q3 2025 · Dec 31, 2023 $89.42M
Current Liabilities Q3 2025 · Sep 30, 2025 $9.48M
Current Liabilities Q3 2025 · Dec 31, 2024 $12.63M
Total Liabilities Q3 2025 · Sep 30, 2025 $48.04M
Total Liabilities Q3 2025 · Dec 31, 2024 $54.75M
Current Assets Q3 2025 · Sep 30, 2025 $23.02M
Current Assets Q3 2025 · Dec 31, 2024 $43.03M
Total Assets Q3 2025 · Sep 30, 2025 $43.71M
Total Assets Q3 2025 · Dec 31, 2024 $66.35M
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.38
Eps Diluted Q3 2025 · Sep 30, 2025 −$14.85
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$9.07
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$63.45
Eps Basic Q3 2025 · Sep 30, 2025 −$3.38
Eps Basic Q3 2025 · Sep 30, 2025 −$14.85
Eps Basic restated Q3 2025 · Sep 30, 2024 −$9.07
Eps Basic restated Q3 2025 · Sep 30, 2024 −$63.45
Sga Expense Q3 2025 · Sep 30, 2025 $2.24M
Sga Expense Q3 2025 · Sep 30, 2025 $9M
Sga Expense Q3 2025 · Sep 30, 2024 $3.93M
Sga Expense Q3 2025 · Sep 30, 2024 $14.89M
Rd Expense Q3 2025 · Sep 30, 2025 $4.05M
Rd Expense Q3 2025 · Sep 30, 2025 $14.03M
Rd Expense Q3 2025 · Sep 30, 2024 $5.9M
Rd Expense Q3 2025 · Sep 30, 2024 $37.4M
Net Income Q3 2025 · Sep 30, 2025 −$5.98M
Net Income Q3 2025 · Sep 30, 2025 −$21.97M
Net Income Q3 2025 · Jun 30, 2025 −$7.44M
Net Income Q3 2025 · Mar 31, 2025 −$8.55M
Net Income Q3 2025 · Sep 30, 2024 −$11.87M
Net Income Q3 2025 · Sep 30, 2024 −$82.46M
Net Income Q3 2025 · Jun 30, 2024 −$48.13M
Net Income Q3 2025 · Mar 31, 2024 −$22.45M
Operating Income Q3 2025 · Sep 30, 2025 −$6.24M
Operating Income Q3 2025 · Sep 30, 2025 −$23.9M
Operating Income Q3 2025 · Sep 30, 2024 −$12.44M
Operating Income Q3 2025 · Sep 30, 2024 −$84.94M
Revenue Q3 2025 · Sep 30, 2025 $25K
Revenue Q3 2025 · Sep 30, 2025 $391K
Revenue Q3 2025 · Sep 30, 2024 $195K
Revenue Q3 2025 · Sep 30, 2024 $1.33M